"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia

NCT02074657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Paediatric Acute Leukaemia

Interventions

BIOLOGICAL: Activated and expanded natural killer cells (NKAEs)

Sponsor

Hospital Universitario La Paz